Clinical trials: Cortisol Excess

Cushing's Syndrome

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

• Completed
• Age: 18 to 80 years
• Phase 2
• Results posted

Cushing's syndrome is a relatively rare disorder caused by prolonged exposure to high levels of the glucocorticoid hormone cortisol. Cushing's syndrome may result from elevated endogenous or exogenous sources of cortisol.

Trial name

NCT02804750

Testing

CORT125134

Where

25 sites in United States, Hungary and 3 more

Volunteers

35 people

Sponsor

Corcept Therapeutics